MARKET

BNTC

BNTC

Benitec Biopharm
NASDAQ
0.3358
+0.0207
+6.57%
After Hours: 0.3640 +0.0282 +8.40% 19:51 10/04 EDT
OPEN
0.3202
PREV CLOSE
0.3151
HIGH
0.3500
LOW
0.3202
VOLUME
187.74K
TURNOVER
0
52 WEEK HIGH
3.900
52 WEEK LOW
0.3009
MARKET CAP
2.74M
P/E (TTM)
-3.0144
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.
Benzinga · 09/27 21:44
BRIEF-Cvi Investments Inc Reports 5.8% Passive Stake In Benitec Biopharma
BRIEF-Cvi Investments Inc Reports 5.8% Passive Stake In Benitec Biopharma
Reuters · 09/23 14:15
HC Wainwright & Co. Maintains Buy on Benitec Biopharma, Lowers Price Target to $4
HC Wainwright & Co. analyst Patrick Trucchio maintains Benitec Biopharma (NASDAQ:BNTC) with a Buy and lowers the price target from $10 to $4.
Benzinga · 09/23 10:48
--HC Wainwright Adjusts Price Target on Benitec Biopharma to $4 From $10, Reiterates Buy Rating
--HC Wainwright Adjusts Price Target on Benitec Biopharma to $4 From $10, Reiterates Buy Rating
MT Newswires · 09/23 07:06
Benitec Biopharma closes ~$17.9M underwritten public offering
Gene therapy-focused biotechnology company Benitec Biopharma (NASDAQ:...
Seekingalpha · 09/16 13:08
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
Benzinga · 09/14 07:58
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Benzinga · 09/13 17:49
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.
Benzinga · 09/13 16:32
More
About BNTC
Benitec Biopharma Inc is an Australia-based biotechnology company. The Company is focused on developing a therapeutic technology platform that combines ribonucleic acid (RNA) interference with gene therapy for the goal of silencing disease-causing genes from a single administration. The Company's technology, deoxyribonucleic acid (DNA)-directed RNA interference (ddRNAi), is used to develop product candidates in chronic and life-threatening human disease areas including orphan disease and infectious disease. Its pipeline includes BB-301, and BB-103. The Company's lead product candidate, BB-301, is used for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD). Its BB-103 pipeline product is being developed for the treatment of chronic hepatitis B Virus infection.

Webull offers kinds of Benitec Biopharma Inc stock information, including NASDAQ:BNTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BNTC stock methods without spending real money on the virtual paper trading platform.